{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["17(1)"],"submitter":["Amiot A"],"pubmed_abstract":["<h4>Background and aims</h4>There are concerns regarding the potential impact of the COVID-19 outbreak on patients with inflammatory bowel disease [IBD]. We report on the impact of the COVID-19 outbreak in a European prospective cohort study of patients with IBD.<h4>Patients and methods</h4>We prospectively collected data from 5457 patients with IBD nested in the ongoing I-CARE project and still followed up in April 2020, with monthly online monitoring of clinical activity, treatment, imaging and endoscopy. Investigators were also contacted to report incidental cases.<h4>Results</h4>In total, 233 [4.3%] reported COVID-19 and 12 [0.2%] severe COVID-19, with no COVID-19 deaths. The risk of COVID-19 in patients with IBD was not increased compared to the general population (standardized incide"],"journal":["Journal of Crohn's & colitis"],"pagination":["37-48"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC9384408"],"repository":["biostudies-literature"],"pubmed_title":["The Impact of COVID-19 on Patients with IBD in a Prospective European Cohort Study."],"pmcid":["PMC9384408"],"pubmed_authors":["Mazhar Z","Mantzaris G","Trang C","Fung M","Abitbol V","Gordon J","Dubois P","Butterworth J","Laharie D","Gornet JM","Filippi J","Hart A","De Vos M","Biancone L","Shitrit A","Vani D","Altwegg R","Staicu A","Hebuterne X","Avni Biron I","Preston C","Mathieu N","Zeissig S","Hasselblatt P","Principi MB","Speight A","Koss K","Shariq S","Rahier JF","Corless L","I-CARE collaborator group","Shenoy A","Elphick D","Kopylov U","Bonnet J","Lowenberg M","Costes L","Roblin X","D’inca R","Farkas K","Yanai H","Burisch J","Locher C","Nahon S","Franchimont D","Nachury M","Ghosh D","Landy J","Siegmund B","Baert F","Vuitton L","Parkes G","Limdi J","Fumery M","Blanc P","Magro F","Sonwalkar S","Valats JC","Maaser C","Pineton De Chambrun G","Heluwaert F","O’morain C","Nancey S","Gilletta C","Michalopoulos G","Dallal H","Karmiris K","Ramadas A","Baburajan B","Amiot A","Domenech E","Abouda G","Hobday D","Zallot C","Wesley E","Singh S","Barberis C","Shenderey R","Viazis N","Bamias G","Macaigne G","Dewitte M","Eder P","Castiglione F","Tsai H","Szepes Z","Theodoropoulou A","Nakad A","Reimund JM","Bouguen G","Bellaiche G","Pelletier AL","Reenears C","Peyrin-Biroulet L","Michiels C","Lobaton T","Doherty G","Phillips A","Burton J","Gangi M","Kirchgesner J","Beaugerie L","Clayton E","Pedersen N","Bell A","Orlando A","Smith K","Calabrese E","Molnar T","Kaassis M"],"additional_accession":[]},"is_claimable":false,"name":"The Impact of COVID-19 on Patients with IBD in a Prospective European Cohort Study.","description":"<h4>Background and aims</h4>There are concerns regarding the potential impact of the COVID-19 outbreak on patients with inflammatory bowel disease [IBD]. We report on the impact of the COVID-19 outbreak in a European prospective cohort study of patients with IBD.<h4>Patients and methods</h4>We prospectively collected data from 5457 patients with IBD nested in the ongoing I-CARE project and still followed up in April 2020, with monthly online monitoring of clinical activity, treatment, imaging and endoscopy. Investigators were also contacted to report incidental cases.<h4>Results</h4>In total, 233 [4.3%] reported COVID-19 and 12 [0.2%] severe COVID-19, with no COVID-19 deaths. The risk of COVID-19 in patients with IBD was not increased compared to the general population (standardized incide","dates":{"release":"2023-01-01T00:00:00Z","publication":"2023 Jan","modification":"2026-05-09T19:38:03.613Z","creation":"2025-04-04T13:55:43.496Z"},"accession":"S-EPMC9384408","cross_references":{"pubmed":["35767639"],"doi":["10.1093/ecco-jcc/jjac091"]}}